Oxidative Medicine and Cellular Longevity, 2020 · DOI: https://doi.org/10.1155/2020/6375938 · Published: August 28, 2020
Ferroptosis is a recently discovered type of cell death distinct from apoptosis, characterized by iron dependence and accumulation of lipid reactive oxygen species (ROS). This process involves specific morphological changes like shrunken mitochondria. The mechanism of ferroptosis involves iron overloading, lipid peroxidation, and downstream execution. Regulation of ferroptosis involves pathways like glutathione/glutathione peroxidase 4, the mevalonate pathway, and the transsulfuration pathway. Recent research highlights the crucial role of selenium in glutathione peroxidase 4 (GPX4) and its ability to suppress ferroptosis. Also, the discovery of ferroptosis suppressor protein 1 (FSP1) has expanded our understanding of ferroptosis mechanisms.
Inhibiting ferroptosis may offer a new therapeutic strategy for promoting neurological recovery and reducing secondary damage in spinal cord injury patients.
Understanding the specific mechanisms of ferroptosis, especially related to selenium and FSP1, can facilitate the development of targeted drugs to combat SCI.
Further research into selenium's role in preventing ferroptosis may pave the way for its clinical application in SCI treatment.